Ident. | Authors (with country if any) | Title |
---|
000076 (2013) |
Alexander J. Stockdale [Royaume-Uni] ; Joseph Nkuranga [Kenya] ; M. Estee Örök [Royaume-Uni] ; Brian Faragher [Royaume-Uni] ; David G. Lalloo [Royaume-Uni] | Initiation of antiretroviral therapy in HIV-infected tuberculosis patients in rural Kenya: an observational study |
000129 (2012) |
David Maman [France] ; Mar Pujades-Rodriguez [France] ; Sarala Nicholas [France] ; Megan Mcguire [France] ; Elisabeth Szumilin [France] ; Rene Ecochard [France] ; Jean-François Etard [France] | Response to antiretroviral therapy: improved survival associated with CD4 above 500 cells/μl |
000188 (2012) |
S. Takuva [Arabie saoudite, Afrique du Sud] ; D. Westreich [États-Unis] ; C. N. Menezes [Afrique du Sud] ; L. Mcnamara [Arabie saoudite] ; I. Sanne [Arabie saoudite, Afrique du Sud] ; L. Page-Shipp [Afrique du Sud] ; M. Maskew [Arabie saoudite] | Antiretroviral therapy initiation during tuberculosis treatment and HIV-RNA and CD4 T-lymphocyte responses |
000222 (2011) |
L. Thairu [États-Unis] ; D. Katzenstein [États-Unis] ; D. Israelski [États-Unis] | Operational challenges in delivering CD4 diagnostics in sub-Saharan Africa |
000233 (2011) |
Peter W. Hunt [États-Unis] ; Huyen L. Cao [États-Unis, Ouganda] ; Conrad Muzoora [Ouganda] ; Isaac Ssewanyana [Ouganda] ; John Bennett [États-Unis] ; Nneka Emenyonu [Ouganda, États-Unis] ; Annet Kembabazi [Ouganda] ; Torsten B. Neilands [États-Unis] ; David R. Bangsberg [Ouganda, États-Unis] ; Steven G. Deeks [États-Unis] ; Jeffrey N. Martin [États-Unis] | Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy |
000291 (2010) |
Stefaan F. Van Der Borght [Pays-Bas] ; Maarten F. Schim Van Der Loeff [Pays-Bas] ; Philippe Clevenbergh [Pays-Bas, France] ; Jean Pierre Kabarega [Rwanda] ; Emmanuel Kamo [Burundi] ; Katinka Van Cranenburgh [Pays-Bas] ; Henk Rijckborst [Pays-Bas] ; Joep M. Lange [Pays-Bas] ; Tobias F. Rinke De Wit [Pays-Bas] | Long-term voluntary counseling and testing (VCT) uptake dynamics in a multicountry HIV workplace program in sub-Saharan Africa |
000464 (2008) |
Rebecca Hammond [Royaume-Uni] ; Tubonye C. Harry [Royaume-Uni] | Efficacy of antiretroviral therapy in Africa : effect on immunological and virological outcome measures -a meta-analysis |
000527 (2007) |
Raoul Moh [Côte d'Ivoire] ; Christine Danel [Côte d'Ivoire] ; Eugène Messou [Côte d'Ivoire] ; Timothée Ouassa [Côte d'Ivoire] ; Delphine Gabillard [Côte d'Ivoire] ; Amani Anzian [Côte d'Ivoire] ; Yao Abo [Côte d'Ivoire] ; Roger Salamon [Côte d'Ivoire, France] ; Emmanuel Bissagnene [Côte d'Ivoire] ; Catherine Seyler [Côte d'Ivoire, France] ; Serge Eholie [Côte d'Ivoire] ; Xavier Anglaret [Côte d'Ivoire, France] | Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa |
000537 (2007) |
Sylvie Deuffic-Burban [France] ; Elena Losina [États-Unis] ; BINGXIA WANG [États-Unis] ; Delphine Gabillard [France] ; Eugène Messou [Côte d'Ivoire] ; Nomita Divi [États-Unis] ; Kenneth A. Freedberg [États-Unis] ; Xavier Anglaret [France] ; Yazdan Yazdanpanah [France] | Estimates of opportunistic infection incidence or death within specific CD4 strata in HIV-infected patients in Abidjan, Côte d'Ivoire : impact of alternative methods of CD4 count modelling |
000543 (2007) |
Souleymane Diabate [Côte d'Ivoire, Canada] ; Michel Alary [Canada] ; Constance Kanga Koffi [Côte d'Ivoire] | Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Côte d'Ivoire |
000549 (2007) |
Carolyn Bolton-Moore [Zambie] ; Mwangelwa Mubiana-Mbewe [Zambie] ; Ronald A. Cantrell [États-Unis] ; Namwinga Chintu [Zambie] ; Elizabeth M. Stringer [Zambie] ; Benjamin H. Chi [Zambie] ; Moses Sinkala [Zambie] ; Chipepo Kankasa [Zambie] ; Craig M. Wilson [États-Unis] ; Catherine M. Wilfert [États-Unis] ; Albert Mwango [Zambie] ; Jens Levy [Zambie] ; Elaine J. Abrams [États-Unis] ; Marc Bulterys [Zambie] ; Jeffrey S. A. Stringer [Zambie, États-Unis] | Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia |
000558 (2007) |
Gary M. Cohen [États-Unis] | Access to diagnostics in support of HIV/AIDS and tuberculosis treatment in dedeveloping countries |
000601 (2006) |
Anju Bansal [États-Unis] ; Ethan Gough [États-Unis] ; Doug Ritter [États-Unis] ; Craig Wilson [États-Unis] ; Joseph Mulenga [États-Unis] ; Susan Allen [États-Unis] ; Paul A. Goepfert [États-Unis] | Group M-based HIV-1 gag peptides are frequently targeted by T cells in chronically infected US and Zambian patients |
000628 (2005) |
Max Katubulushi [Zambie] ; Isaac Zulu [Zambie] ; Felistah Yavwa [Zambie] ; Paul Kelly [Zambie] | Slow decline in CD4 cell count in a cohort of HIV-infected adults living in Lusaka, Zambia |
000634 (2005) |
P. A. Venkatesh [États-Unis] ; R. J. Bosch [États-Unis] ; K. Mcintosh [États-Unis] ; F. Mugusi [Tanzanie] ; G. Msamanga [Tanzanie] ; W. W. Fawzi [États-Unis] | Predictors of incident tuberculosis among HIV-1-infected women in Tanzania |
000683 (2004) |
Motasim Badri [Afrique du Sud] ; Linda-Gail Bekker [Afrique du Sud] ; Catherine Orrell [Afrique du Sud] ; Jennifer Pitt [Afrique du Sud] ; Francois Cilliers [Afrique du Sud] ; Robin Wood [Afrique du Sud] | Initiating highly active antiretroviral therapy in sub-Saharan Africa: an assessment of the revised World Health Organization scaling-up guidelines |
000684 (2004) |
Marianne A. B. Van Der Sande [Gambie] ; Maarten F. Schim Van Der Loeff [Royaume-Uni] ; Rachel C. Bennett [Gambie] ; Mary Dowling [Gambie] ; Akum A. Aveika [Gambie] ; Toyin O. Togun [Gambie] ; Saihou Sabally [Gambie] ; David Jeffries [Gambie] ; Richard A. Adegbola [Gambie] ; Ramu Sarge-Njie [Gambie] ; Assan Jaye [Gambie] ; Tumani Corrah [Gambie] ; Samuel Mcconkey [Gambie] ; Hilton C. Whittle [Gambie] | Incidence of tuberculosis and survival after its diagnosis in patients infected with HIV-1 and HIV-2 |
000687 (2004) |
Dominique Bonard [Côte d'Ivoire] ; Eugène Messou [Côte d'Ivoire] ; Catherine Seyler [Côte d'Ivoire] ; Véronique Vincent [France] ; Delphine Gabillard [France] ; Xavier Anglaret [Côte d'Ivoire, France] | High incidence of atypical mycobacteriosis in African HIV-infected adults with low CD4 cell counts: a 6-year cohort study in Côte d'Ivoire |
000711 (2003) |
Ann Chapman [Royaume-Uni] ; Ajit Lalvani [Royaume-Uni] | Rapid detection of mycobacterium tuberculosis infection in HIV-infected zambians by enumeration of RD1 gene product-specific T cells by Chapman ALN |
000724 (2003) |
E. Sandström [Suède] ; W. Urassa [Tanzanie] ; M. Bakari [Suède] ; A. Swai [Tanzanie] ; F. Mhalu [Tanzanie] ; G. Biberfeld [Suède] ; K. Pallangyo [Tanzanie] | Estimation of CD4 T-lymphocyte counts from percent CD4 T-lymphocyte determinations in HIV-1-infected subjects in sub-Saharan Africa |
000755 (2002) |
Paul Kelly [Zambie, Royaume-Uni] ; Isaac Zulu [Zambie, Royaume-Uni] ; Beatrice Amadi [Zambie] ; Mwansa Munkanta [Zambie] ; Jacqueline Banda [Zambie] ; Laura C. Rodrigues [Royaume-Uni] ; David Mabey [Royaume-Uni] ; Roger Feldman [Royaume-Uni] ; Michael J. G. Farthing [Royaume-Uni] | Morbidity and nutritional impairment in relation to CD4 count in a Zambian population with high HIV prevalence |